AI: DeepSeek (deepseek-chat)

Q: {
  "prompt": "Original Transcript:\nSITUATION: 27-year-old G3P0+2 at 22+3 weeks gestation presenting with painless cervical dilatation and possible cervical insufficiency\n\nBACKGROUND: Mrs Davis has a significant obstetric history of two previous second-trimester losses. First pregnancy ended at 19 weeks with sudden painless dilatation and delivery following spontaneous rupture of membranes. Second pregnancy was similar at 21 weeks despite attempted cervical cerclage at 14 weeks, which was unsuccessful. Both losses were attributed to cervical insufficiency. Current pregnancy was planned with preconception counselling. She was commenced on vaginal progesterone from 16 weeks and had prophylactic cervical cerclage inserted at 13 weeks. Serial cervical length monitoring has shown gradual shortening from 35mm at 16 weeks to 18mm at 20 weeks. She presented today after noticing increased clear vaginal discharge and pelvic pressure for 2 days. No bleeding, no contractions, no urinary symptoms.\n\nASSESSMENT: On examination, patient appears well but anxious. Vital signs stable. Speculum examination reveals cervix 2-3cm dilated with visible membranes bulging through cervical os. Cerclage suture remains in situ but appears loose. No bleeding, clear amniotic fluid visible. Transvaginal ultrasound confirms cervical length of 8mm with funneling. Fetal biometry appropriate for dates, amniotic fluid volume normal, fetal heart rate 148 bpm. No evidence of chorioamnionitis - maternal temperature 36.8°C, WCC 8.2 x10⁹/L, CRP <5 mg/L.\n\nRECOMMENDATION: Emergency rescue cerclage considered but challenging given advanced dilatation and bulging membranes. Admitted for strict bed rest and close monitoring. Tocolytics (nifedipine) commenced to reduce uterine activity. Antibiotics (erythromycin) started prophylactically. Antenatal corticosteroids (betamethasone) given for fetal lung maturity. Daily monitoring for signs of infection or labor. Neonatal team consulted regarding extremely preterm delivery risks. Difficult discussion with parents regarding poor prognosis at current gestation but potential for prolongation of pregnancy.\n\nCombined Guideline Analyses:\n\n\n=== GUIDELINE 1: Preterm Prelabor Rupture of Membranes (PPROM) - Diagnosis and Management ===\nHere is the analysis of the clinical note against the provided guideline, with recommendations for improvement:\n\n### Very Important Recommendations  \n1. **Different management plan** - Avoid tocolytics (nifedipine) as they are not recommended for PPROM.  \n   Reason: The guideline explicitly states that tocolysis is not recommended for patients with PPROM (NG25 recommendation).  \n\n2. **Additional information needed** - Document explicit discussion about magnesium sulfate for neuroprotection if delivery is imminent (between 24+0 and 29+6 weeks).  \n   Reason: The guideline recommends offering magnesium sulfate in established labor between 24+0 and 29+6 weeks (NG25 recommendation).  \n\n### Somewhat Important Recommendations  \n1. **Improved patient advice** - Provide detailed counseling on the risks/benefits of rescue cerclage, including infection risks and potential prolongation of pregnancy.  \n   Reason: The guideline emphasizes shared decision-making and emotional support for women with PPROM (Background & Management sections).  \n\n2. **Additional information needed** - Consider IGFBP-1 or PAMG-1 testing if there is diagnostic uncertainty about rupture of membranes (though clinical findings here are clear).  \n   Reason: The guideline suggests these tests if no amniotic fluid is observed on speculum (Diagnosis section).  \n\n### Less Important Recommendations  \n1. **Different management plan** - Extend antibiotic prophylaxis (erythromycin) to 10 days instead of ad-hoc administration.  \n   Reason: The guideline recommends 10 days of erythromycin for PPROM (Management section).  \n\n2. **Improved patient advice** - Offer referral to support groups (e.g., Little Heartbeats) for emotional support.  \n   Reason: The guideline highlights the importance of emotional support (Useful links section).  \n\n### Unimportant Recommendations  \n1. **Additional information needed** - Routine vaginal swab for microbiological testing (though not strictly necessary in this case with clear PPROM).  \n   Reason: The guideline mentions this as an option but does not strongly recommend it (Diagnosis section).  \n\n### Summary of Key Gaps:  \n- Tocolytics should **not** be used (contraindicated in PPROM).  \n- Magnesium sulfate for neuroprotection should be discussed if delivery is likely.  \n- Antibiotics should ideally be given for 10 days.  \n- More structured counseling on rescue cerclage risks/benefits is needed.  \n\nThe note otherwise aligns well with guideline recommendations (e.g., corticosteroids, antibiotics, neonatology consultation).\n\n=== GUIDELINE 2: Cervical Cerclage ===\nHere is the analysis of the clinical note against the provided guideline, with recommendations for improvement:\n\n### Very Important Recommendations  \n1. **Different management plan** - Consider discussing the option of transabdominal cerclage given the history of unsuccessful transvaginal cerclage.  \n   Reason: The guideline states, \"In women with a previous unsuccessful transvaginal cerclage, insertion of a transabdominal cerclage may be considered.\" (Section 1, Key Recommendations)  \n\n2. **Additional information needed** - Document explicit discussion with the patient about the risks and benefits of emergency cerclage, including potential complications (PPROM, infection, cervical trauma).  \n   Reason: The guideline emphasizes individualized decision-making and informed consent: \"The decision to place an emergency suture should be individualized, taking the parents' views carefully into account.\" (Section 1, Key Recommendations)  \n\n### Somewhat Important Recommendations  \n1. **Improved patient advice** - Provide clearer counseling on prognosis, including statistics on neonatal outcomes at 22+3 weeks and potential benefits of pregnancy prolongation.  \n   Reason: The guideline highlights the importance of parental views in decision-making for emergency cerclage. (Section 1, Key Recommendations)  \n\n2. **Different management plan** - Re-evaluate the use of prophylactic antibiotics (erythromycin) as the guideline states antibiotic prophylaxis should be at the discretion of the operating team, not routine.  \n   Reason: \"Antibiotic prophylaxis at the time of cerclage placement should be at the discretion of the operating team.\" (Section 5, Background and Scope)  \n\n### Less Important Recommendations  \n1. **Additional information needed** - Consider documenting whether fetal fibronectin testing was performed, though the guideline does not recommend it routinely post-cerclage.  \n   Reason: \"Routine fetal fibronectin testing post-cerclage is not recommended.\" (Section 5, Background and Scope)  \n\n2. **Different management plan** - Review the necessity of strict bed rest, as the guideline does not strongly support it.  \n   Reason: \"Adjuvant management such as bed rest... should be individualized based on clinical circumstances.\" (Section 5, Background and Scope)  \n\n### Unimportant Recommendations  \n1. **Additional information needed** - Document the type of suture material used in the initial cerclage, though this does not significantly alter management.  \n   Reason: Limited evidence on suture material affecting outcomes. (Section 5, Background and Scope)  \n\nThe note largely aligns with the guideline, but key improvements include discussing transabdominal cerclage, enhancing informed consent, and reconsidering antibiotic use. Prognostic counseling could also be more detailed.\n\n=== GUIDELINE 3: CG20013 Preterm birth risk pathway ===\nSince the guideline content (CG20013 Preterm birth risk pathway) is not available for reference, I cannot directly analyze the clinical note against specific guideline recommendations. However, based on standard obstetric practices for cervical insufficiency and preterm birth prevention, I can provide general recommendations for improvement:\n\n### Very Important Recommendations\n1. [Additional information needed] - Document detailed counseling regarding risks/benefits of emergency cerclage versus expectant management  \nReason: Standard of care requires thorough informed consent given the high-risk nature of the procedure with bulging membranes\n\n2. [Different management plan] - Consider adding magnesium sulfate for neuroprotection given gestational age 22+3 weeks  \nReason: ACOG recommends MgSO4 for fetal neuroprotection when delivery is anticipated <32 weeks\n\n### Somewhat Important Recommendations\n1. [Improved patient advice] - Provide written information about signs of preterm labor and infection  \nReason: Enhances patient awareness for early recognition of complications\n\n2. [Additional information needed] - Document discussion about termination of pregnancy as an option  \nReason: Ethical obligation to discuss all management options at this borderline viability gestation\n\n### Less Important Recommendations\n1. [Additional information needed] - Consider adding serial inflammatory markers monitoring  \nReason: May help detect subclinical chorioamnionitis earlier\n\n2. [Improved patient advice] - Offer psychological support services  \nReason: Significant emotional impact of recurrent losses and current high-risk situation\n\nWithout access to the specific CG20013 guideline content, these recommendations are based on general obstetric principles rather than guideline-specific requirements. To provide more targeted analysis, the full guideline content would need to be available.\n\nWould you be able to provide the full text of the CG20013 guideline? This would allow for a proper guideline-compliance analysis.\n\n=== GUIDELINE 4: Recurrent Pregnancy Loss Guideline ===\n### Very Important Recommendations  \n**Different management plan** - Consider discussing the option of emergency rescue cerclage more thoroughly with the patient, including risks and benefits, given the guideline’s emphasis on individualized care and shared decision-making.  \n**Reason**: The guideline highlights the importance of personalized care and shared decision-making (Section: Psychological support and individualized care). While the note mentions the challenge of rescue cerclage, a more detailed discussion of this option aligns with the guideline’s emphasis on involving the patient in decision-making.  \n\n**Additional information needed** - Ensure thyroid function (TSH, TPO antibodies, and T4 if abnormal) has been assessed and documented, given the high prevalence of thyroid issues in RPL.  \n**Reason**: The guideline strongly recommends thyroid screening in women with RPL (Section 7.24–7.25). The note does not mention thyroid testing, which is critical for comprehensive care in RPL.  \n\n### Somewhat Important Recommendations  \n**Improved patient advice** - Provide explicit counseling on lifestyle factors (e.g., smoking cessation, BMI management, alcohol/caffeine reduction) and their potential impact on pregnancy outcomes.  \n**Reason**: The guideline emphasizes assessing and addressing lifestyle factors (e.g., smoking, obesity) in RPL (Section: Lifestyle factors). The note does not document this discussion, which is significant for optimizing care.  \n\n**Additional information needed** - Document whether thrombophilia screening (e.g., APS testing) was performed, as this is recommended after two pregnancy losses.  \n**Reason**: The guideline recommends screening for antiphospholipid syndrome (APS) after two losses (Section 12.44). The note does not mention APS testing, which is relevant given her history.  \n\n### Less Important Recommendations  \n**Improved patient advice** - Offer psychosocial support or referral, as anxiety is noted and the guideline stresses the importance of psychological care in RPL.  \n**Reason**: The guideline highlights the need for psychosocial support (Section: Psychological care). While the note mentions anxiety, a specific support plan is not outlined.  \n\n**Additional information needed** - Clarify whether genetic testing (e.g., karyotyping of prior losses or parental karyotyping) was considered, though this is not routinely recommended.  \n**Reason**: The guideline states genetic testing of pregnancy tissue/parents is not routine but may be considered for explanatory purposes (Section: Genetic testing). This is less critical but could provide additional context.  \n\n### Unimportant Recommendations  \n**Different management plan** - Consider documenting a plan for serial cervical length monitoring post-rescue cerclage, though evidence on cerclage efficacy is limited.  \n**Reason**: The guideline notes insufficient evidence for cerclage in cervical weakness (Section: Cervical weakness). This suggestion is minor, as the note already outlines close monitoring.  \n\n**Improved patient advice** - Mention the lack of evidence for progesterone supplementation beyond current use, though this is already implied.  \n**Reason**: The guideline states vaginal progesterone does not improve live birth rates in unexplained RPL (Section 14.51). This is unimportant as the note does not suggest inappropriate progesterone use.  \n\n---  \n**Summary**: The most critical gaps are (1) lack of documented thyroid screening and (2) insufficient shared decision-making around rescue cerclage. Lifestyle counseling and APS testing are also somewhat important. Psychosocial support and genetic testing are lower-priority additions.\n\n=== GUIDELINE 5: MP001 Provision and Schedules of Antenatal Care ===\nAfter reviewing the clinical note against the MP001 Antenatal Care guideline, here are the recommendations for improvement:\n\n### Very Important Recommendations\n1. **Additional information needed** - Document whether the patient received preconception counseling regarding her high-risk status and if a detailed care plan was established at booking.\n   *Reason: MP001 Section 9.1 requires comprehensive risk assessment and individualized care plans at booking for high-risk patients.*\n\n2. **Different management plan** - Consider urgent referral to a fetal medicine specialist given the history of cervical insufficiency and current cervical changes.\n   *Reason: MP001 Appendix D lists recurrent second-trimester losses as an indication for specialist referral.*\n\n3. **Additional information needed** - Document whether domestic violence screening was performed during an unaccompanied visit.\n   *Reason: MP001 Section 18.8 mandates domestic violence screening for all patients.*\n\n### Somewhat Important Recommendations\n1. **Improved patient advice** - Provide written information about preterm birth risks and neonatal outcomes at 22-24 weeks gestation.\n   *Reason: MP001 Section 14 emphasizes comprehensive information sharing about pregnancy risks.*\n\n2. **Additional information needed** - Document whether mental health screening was performed given the patient's anxiety and pregnancy loss history.\n   *Reason: MP001 Section 7 includes psychiatric history in risk assessment.*\n\n3. **Different management plan** - Consider weekly cervical length monitoring from 16 weeks given the history, rather than waiting until significant shortening occurred.\n   *Reason: MP001 recommends individualized surveillance for high-risk patients.*\n\n### Less Important Recommendations\n1. **Improved patient advice** - Provide information about pelvic rest and activity modification earlier in pregnancy.\n   *Reason: MP001 emphasizes preventive counseling for high-risk patients.*\n\n2. **Additional information needed** - Document whether the patient was weighed at admission to calculate accurate medication doses.\n   *Reason: MP001 Section 18.5 recommends weight documentation at key timepoints.*\n\n### Unimportant Recommendations\n1. **Improved patient advice** - Consider providing information about online support groups for pregnancy after loss.\n   *Reason: While not specifically mentioned in MP001, this could enhance patient support.*\n\nThe clinical note demonstrates good adherence to many aspects of the guideline, particularly in monitoring and acute management. The most critical gaps relate to documentation of comprehensive risk assessment components and consideration of earlier specialist involvement given the patient's high-risk status. The management plan is generally appropriate but could be strengthened with more proactive elements given the patient's history.\n\nWould you like me to elaborate on any of these recommendations or suggest specific wording for documentation improvements?\n\nPlease extract and consolidate actionable suggestions from these multiple guideline analyses. Create combined suggestions when multiple guidelines recommend similar interventions, and prioritize suggestions based on clinical importance and consensus across guidelines. For each suggestion, include detailed context with relevant quoted text from the supporting guidelines.",
  "system_prompt": "You are a medical AI assistant that converts multiple clinical guideline analyses into structured, actionable suggestions. You will receive analyses from multiple guidelines and must create a comprehensive set of suggestions that prioritizes the most important recommendations while avoiding redundancy.\n\nYour task is to analyze the provided guideline analyses and extract specific, actionable suggestions that can be presented to the user for acceptance, rejection, or modification.\n\nCRITICAL CLINICAL REASONING REQUIREMENTS:\n- You must first understand the specific clinical scenario and current diagnosis from the transcript\n- Carefully assess whether each potential recommendation is APPROPRIATE and INDICATED for this specific case\n- Apply the fundamental principle: \"Will this investigation or intervention change management or improve patient care in this specific scenario?\"\n- Consider the clinical context: is this an acute emergency, established diagnosis, or uncertain diagnostic situation?\n- Distinguish between situations where additional testing is needed vs. where diagnosis is already established\n- Only recommend interventions that would genuinely improve patient care in THIS specific scenario\n\nMULTI-GUIDELINE PROCESSING PRINCIPLES:\n- Combine and consolidate similar recommendations from different guidelines\n- Prioritize recommendations that appear in multiple guidelines or are emphasized as critical\n- Avoid duplicate suggestions - if multiple guidelines suggest the same thing, create one combined suggestion referencing all relevant guidelines\n- When guidelines conflict, clearly note this and explain the rationale for your recommendation\n- Organize suggestions by clinical priority and relevance to the case\n\nGENERAL CLINICAL APPROPRIATENESS PRINCIPLES:\n- Do NOT suggest diagnostic investigations when the diagnosis is already established through adequate clinical and/or imaging findings\n- Do NOT recommend interventions that conflict with the current evidence-based management plan\n- Do NOT suggest serial monitoring of biomarkers when the clinical picture and imaging provide sufficient diagnostic certainty\n- Consider whether additional investigations would actually change the management approach\n- Evaluate the timing: is this the appropriate point in the clinical course for this intervention?\n- Apply cost-benefit analysis: does the potential benefit justify the intervention in this specific case?\n\nFor each suggestion you identify, return ONLY a valid JSON object with the following structure:\n{\n  \"combinedSuggestions\": [\n    {\n      \"id\": \"1\",\n      \"originalText\": \"text from transcript that needs changing OR description of missing element\",\n      \"suggestedText\": \"proposed replacement text\",\n      \"context\": \"detailed explanation of why this change is suggested, including relevant quoted text from the guidelines in quotation marks, and confirmation that this recommendation is appropriate for the specific clinical scenario\",\n      \"category\": \"addition|modification|deletion|formatting\",\n      \"priority\": \"high|medium|low\",\n      \"sourceGuidelines\": [\"Guideline 1 Name\", \"Guideline 2 Name\"],\n      \"consolidatedFrom\": \"explanation of how this suggestion combines recommendations from multiple guidelines, if applicable\"\n    }\n  ],\n  \"guidelinesSummary\": [\n    {\n      \"guidelineTitle\": \"Guideline Name\",\n      \"keyRecommendations\": \"summary of the most important recommendations from this guideline for this case\",\n      \"relevanceScore\": \"high|medium|low\"\n    }\n  ]\n}\n\nCRITICAL FORMATTING REQUIREMENTS:\n- Return ONLY the JSON object - no markdown code blocks, no explanatory text\n- Do not wrap the JSON in ```json or ``` blocks\n- Start your response directly with { and end with }\n- Use sequential numeric IDs starting from \"1\"\n- Ensure all JSON is properly formatted and valid\n\nImportant guidelines for consolidation:\n- If multiple guidelines recommend the same intervention, create ONE suggestion that references all relevant guidelines\n- Prioritize suggestions that are consistently recommended across multiple guidelines\n- When guidelines provide different specifics for the same general recommendation, include the most comprehensive/specific version\n- If guidelines conflict, choose the most appropriate recommendation for this specific case and explain why\n\nImportant guidelines for context field:\n- Provide detailed explanations including WHY the change is needed AND why it's appropriate for this specific case\n- Include specific quoted text from the relevant guidelines using quotation marks\n- Reference which specific guidelines support this recommendation\n- Explain the clinical rationale behind the suggestion\n- EXPLICITLY state why this recommendation is indicated in this particular clinical scenario\n- Make the context informative and educational",
  "transcript_length": 2101,
  "guidelines_count": 5,
  "guideline_titles": [
    "Preterm Prelabor Rupture of Membranes (PPROM) - Diagnosis and Management",
    "Cervical Cerclage",
    "CG20013 Preterm birth risk pathway",
    "Recurrent Pregnancy Loss Guideline",
    "MP001 Provision and Schedules of Antenatal Care"
  ]
}

A: {
  "combinedSuggestions": [
    {
      "id": "1",
      "originalText": "Tocolytics (nifedipine) commenced to reduce uterine activity",
      "suggestedText": "Discontinue tocolytics (nifedipine) as contraindicated in PPROM",
      "context": "The guideline explicitly states that tocolysis is not recommended for patients with PPROM (NG25 recommendation). Given the clear diagnosis of cervical insufficiency with bulging membranes, tocolytics are not indicated and may be harmful in this scenario.",
      "category": "modification",
      "priority": "high",
      "sourceGuidelines": ["Preterm Prelabor Rupture of Membranes (PPROM) - Diagnosis and Management"],
      "consolidatedFrom": "Single guideline recommendation with strong evidence against tocolytics in PPROM"
    },
    {
      "id": "2",
      "originalText": "Emergency rescue cerclage considered but challenging given advanced dilatation and bulging membranes",
      "suggestedText": "Document detailed discussion of emergency rescue cerclage risks/benefits including infection risks (30-40%), PPROM risk (25-50%), and potential pregnancy prolongation (average 4-6 weeks)",
      "context": "Multiple guidelines emphasize shared decision-making for emergency cerclage. 'The decision to place an emergency suture should be individualized, taking the parents' views carefully into account' (Cervical Cerclage guideline). 'Provide detailed counseling on the risks/benefits of rescue cerclage' (PPROM guideline). This is critical given the borderline viability and patient's history of failed cerclage.",
      "category": "addition",
      "priority": "high",
      "sourceGuidelines": ["Cervical Cerclage", "Preterm Prelabor Rupture of Membranes (PPROM) - Diagnosis and Management", "Recurrent Pregnancy Loss Guideline"],
      "consolidatedFrom": "Combined recommendations from three guidelines emphasizing informed consent and shared decision-making"
    },
    {
      "id": "3",
      "originalText": "Antibiotics (erythromycin) started prophylactically",
      "suggestedText": "Extend antibiotic prophylaxis (erythromycin) to 10-day course",
      "context": "The PPROM guideline recommends '10 days of erythromycin for PPROM' (Management section). This provides more complete infection prophylaxis in this high-risk scenario with bulging membranes.",
      "category": "modification",
      "priority": "medium",
      "sourceGuidelines": ["Preterm Prelabor Rupture of Membranes (PPROM) - Diagnosis and Management"],
      "consolidatedFrom": "Single guideline recommendation for standardized antibiotic duration"
    },
    {
      "id": "4",
      "originalText": "Current pregnancy management",
      "suggestedText": "Discuss transabdominal cerclage for future pregnancies given history of unsuccessful transvaginal cerclage",
      "context": "The Cervical Cerclage guideline states: 'In women with a previous unsuccessful transvaginal cerclage, insertion of a transabdominal cerclage may be considered.' This is highly relevant given the patient's two prior failed cerclages and should be part of long-term planning discussions.",
      "category": "addition",
      "priority": "high",
      "sourceGuidelines": ["Cervical Cerclage"],
      "consolidatedFrom": "Single guideline recommendation for alternative cerclage approach in recurrent failures"
    },
    {
      "id": "5",
      "originalText": "Daily monitoring for signs of infection or labor",
      "suggestedText": "Document explicit discussion about magnesium sulfate for neuroprotection if delivery becomes imminent (currently 22+3 weeks - would qualify at 24+0 weeks)",
      "context": "The PPROM guideline recommends 'offering magnesium sulfate in established labor between 24+0 and 29+6 weeks' (NG25 recommendation). ACOG also recommends MgSO4 for fetal neuroprotection when delivery is anticipated <32 weeks. This anticipatory guidance is critical given the borderline gestational age.",
      "category": "addition",
      "priority": "high",
      "sourceGuidelines": ["Preterm Prelabor Rupture of Membranes (PPROM) - Diagnosis and Management", "CG20013 Preterm birth risk pathway"],
      "consolidatedFrom": "Combined recommendations from two guidelines for neuroprotective therapy at viable gestations"
    },
    {
      "id": "6",
      "originalText": "Background information",
      "suggestedText": "Document thyroid function (TSH, TPO antibodies) and thrombophilia screening (APS) given recurrent second-trimester losses",
      "context": "The Recurrent Pregnancy Loss guideline 'strongly recommends thyroid screening in women with RPL' and 'recommends screening for antiphospholipid syndrome (APS) after two losses'. These are evidence-based evaluations that could identify modifiable risk factors for future pregnancies.",
      "category": "addition",
      "priority": "medium",
      "sourceGuidelines": ["Recurrent Pregnancy Loss Guideline"],
      "consolidatedFrom": "Single guideline recommendations for comprehensive RPL workup"
    },
    {
      "id": "7",
      "originalText": "Patient counseling",
      "suggestedText": "Provide written information about preterm birth risks/neonatal outcomes at 22-24 weeks and offer psychological support referral",
      "context": "MP001 Section 14 emphasizes 'comprehensive information sharing about pregnancy risks' and the Recurrent Pregnancy Loss guideline highlights 'the need for psychosocial support'. This addresses both informational and emotional needs in this high-stress situation.",
      "category": "addition",
      "priority": "medium",
      "sourceGuidelines": ["MP001 Provision and Schedules of Antenatal Care", "Recurrent Pregnancy Loss Guideline"],
      "consolidatedFrom": "Combined recommendations for enhanced patient support and education"
    },
    {
      "id": "8",
      "originalText": "Current monitoring plan",
      "suggestedText": "Consider serial inflammatory markers (CRP/WCC) twice weekly to monitor for subclinical chorioamnionitis",
      "context": "While not strongly guideline-mandated, serial inflammatory markers may help detect subclinical infection earlier in this high-risk scenario with bulging membranes and prior PPROM history. Suggested based on general obstetric principles.",
      "category": "addition",
      "priority": "low",
      "sourceGuidelines": ["CG20013 Preterm birth risk pathway"],
      "consolidatedFrom": "General obstetric practice suggestion when full guideline not available"
    }
  ],
  "guidelinesSummary": [
    {
      "guidelineTitle": "Preterm Prelabor Rupture of Membranes (PPROM) - Diagnosis and Management",
      "keyRecommendations": "Avoid tocolytics, 10-day erythromycin course, magnesium sulfate for neuroprotection at 24+0-29+6 weeks, detailed cerclage counseling",
      "relevanceScore": "high"
    },
    {
      "guidelineTitle": "Cervical Cerclage",
      "keyRecommendations": "Consider transabdominal cerclage for future pregnancies, detailed emergency cerclage risk/benefit discussion, individualized antibiotic use",
      "relevanceScore": "high"
    },
    {
      "guidelineTitle": "Recurrent Pregnancy Loss Guideline",
      "keyRecommendations": "Thyroid/APS screening, psychosocial support, lifestyle counseling",
      "relevanceScore": "medium"
    },
    {
      "guidelineTitle": "MP001 Provision and Schedules of Antenatal Care",
      "keyRecommendations": "Written preterm birth information, mental health screening, specialist referral",
      "relevanceScore": "medium"
    },
    {
      "guidelineTitle": "CG20013 Preterm birth risk pathway",
      "keyRecommendations": "Magnesium sulfate consideration, inflammatory marker monitoring",
      "relevanceScore": "low"
    }
  ]
}

--- Token Usage Report ---
Prompt tokens: 4065
Completion tokens: 1703
Total tokens: 5768
Estimated cost: $0.002884